id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-267748-uzt8a5nx	Shiohara, Tetsuo	Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19	2020-09-24		.txt	text/plain	926	32	27	key: cord-267748-uzt8a5nx authors: Shiohara, Tetsuo; Mizukawa, Yoshiko title: Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 date: 2020-09-24 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16959 sha: doc_id: 267748 cord_uid: uzt8a5nx We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug‐induced hypersensitivity syndrome (DiHS), in a COVID‐19 patient:(1) the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine. We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DiHS), in a COVID-19 patient: 1 the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine.	cache/cord-267748-uzt8a5nx.txt	txt/cord-267748-uzt8a5nx.txt
